I guarantee weight loss would be on Dr T's list of potential uses of Bisantrene.
This is a grab from a global drug forecast and market analysis. As we can see, total expected sales in 2022 are (I'm assuming USD) USD $8.4 B. Another grab from a report states that "The Global Anti-obesity Prescription Drugs Market is expected to grow from USD 9,909.80 Million in 2019 to USD 16,094.08 Million by the end of 2025 at a Compound Annual Growth Rate (CAGR) of 8.41%".
It seems that any further information is limited, as many market analysts have looked into this, but there are few who are prepared to share their research for free.
Pillar 1 - FTO (new thread), page-32
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.045(2.80%) |
Mkt cap ! $260.3M | |||
| Open | High | Low | Value | Volume |
| $1.60 | $1.60 | $1.55 | $94.33K | 60.12K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1250 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.59 | 5000 | 1 |
View Market Depth
| Last trade - 14.37pm 16/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.56 |
Change
-0.045 ( 1.17 %) |
||||
| Open | High | Low | Volume | ||
| $1.58 | $1.59 | $1.55 | 8174 | ||
| Last updated 14.21pm 16/05/2024 ? | |||||
| RAC (ASX) Chart |